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Quantifying Acute Myocardial Injury Using Ratiometric Fluorometry
Abstract
Early reperfusion is the best therapy for myocardial infarction (MI). Effectiveness, however, varies
significantly between patients and has implications for long-term prognosis and treatment. A technique to
assess the extent of myocardial salvage after reperfusion therapy would allow for high-risk patients to be
identified in the early post-MI period. Mitochondrial dysfunction is associated with cell death following
myocardial reperfusion and can be quantified by fluorometry. Therefore, we hypothesized that variations
in the fluorescence of mitochondrial nicotinamide adenine dinucleotide (NADH) and flavoprotein (FP) can
be used acutely to predict the degree of myocardial injury. Thirteen rabbits had coronary occlusion for 30
min followed by 3 h of reperfusion. To produce a spectrum of infarct sizes, six animals were infused
cyclosporine A prior to ischemia. Using a specially designed fluorometric probe, NADH and FP
fluorescence were measured in the ischemic area. Changes in NADH and FP fluorescence, as early as 15
min after reperfusion, correlated with postmortem assessment infarct size (r=0.695, p<0.01). This
correlation strengthened with time (r=0.827, p<0.01 after 180 min). Clinical application of catheter-based
myocardial fluorometry may provide a minimally invasive technique for assessing the early response to
reperfusion therapy.
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Abstract—Early reperfusion is the best therapy for myocardial infarction (MI). Effectiveness, however, varies significantly
between patients and has implications for long-term prognosis and
treatment. A technique to assess the extent of myocardial salvage
after reperfusion therapy would allow for high-risk patients to
be identified in the early post-MI period. Mitochondrial dysfunction is associated with cell death following myocardial reperfusion
and can be quantified by fluorometry. Therefore, we hypothesized
that variations in the fluorescence of mitochondrial nicotinamide
adenine dinucleotide (NADH) and flavoprotein (FP) can be used
acutely to predict the degree of myocardial injury. Thirteen rabbits
had coronary occlusion for 30 min followed by 3 h of reperfusion.
To produce a spectrum of infarct sizes, six animals were infused
cyclosporine A prior to ischemia. Using a specially designed fluorometric probe, NADH and FP fluorescence were measured in the
ischemic area. Changes in NADH and FP fluorescence, as early as
15 min after reperfusion, correlated with postmortem assessment
infarct size (r = 0.695, p < 0.01). This correlation strengthened
with time (r = 0.827, p < 0.001 after 180 min). Clinical application of catheter-based myocardial fluorometry may provide a
minimally invasive technique for assessing the early response to
reperfusion therapy.
Index Terms—Apoptosis, fluorometery, mitochondrial disruption, mitochondrial redox state, myocardial infarction, myocardial
reperfusion injury.

I. INTRODUCTION

O

VER THE past 35 years, techniques to identify and revascularize ischemic myocardium have been developed to a
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high level. Despite this, a mass epidemic of congestive heart
failure (CHF) due to coronary disease has developed [1]. Five
million Americans suffer from CHF with 550 000 new cases
diagnosed each year. Sixty-eight percent of these cases are due
to coronary disease [1]. After myocardial infarction (MI), CHF
is preceded by infarct expansion (i.e., the infarct stretches), progressive generalized left ventricular (LV) dilatation, and contractile dysfunction. This deleteriously progressive phenomenon has
been termed postinfarction LV remodeling [2].
Once the remodeling process is established, the symptoms of
CHF ensuing five-year survival, even with the most aggressive
medical and surgical therapy, is about 50% [3]. These dismal
results have generated a strong interest in developing mechanical strategies for preventing infarct expansion, the resulting LV
dilation, and failure.
Recent work in chronic large animal heart failure models
has demonstrated that early restraint to prevent infarct stretching significantly limits ventricular dilation and preserves function [4]–[6]. Despite compelling experimental data, these techniques currently have limited clinical applicability due to an
inability to identify patients early (days after infarction) at risk
for remodeling. While infarct size has long been understood
to correlate with the ultimate degree of ventricular remodeling [7], [8], it is a difficult parameter to quantify particularly
early after reperfusion therapy.
Mitochondrial dysfunction and disruption are known to be intimately involved in both necrotic and apoptotic processes that
lead to cell death following myocardial reperfusion [9], [10].
As a result, in vivo quantitative assessment of mitochondrial
function may provide a method for assessing infarct size above
what is currently provided by angiography and echocardiography [11], [12].
Toward this end, we have developed an optical catheter device to acquire fluorescence signals of the intrinsic mitochondrial fluorophores, nicotinamide adenine dinucleotide (NADH),
and flavoprotein (FP). The ratio of these fluorescence signals
(FP/FP + NADH), defined as the redox ratio (RR), has been
shown to correlate with different metabolic states and mitochondrial function [13], [14]. Additionally, the RR has been shown to
undergo an oxidative shift in tumor cells with mitochondrial dysfunction associated with apoptosis [15]. We hypothesize that the
RR within the ischemic zone, as measured by our device, can
be directly correlated with infarct size early after myocardial
reperfusion. Proof of such a correlation would indicate fiberoptically assessed mitochondrial fluorescence to be a quantitative tool to assess myocardial injury without invasive tissue
biopsy.

0018-9294/$25.00 © 2009 IEEE
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II. MATERIALS AND METHODS
A well-characterized rabbit model of ischemia-reperfusion
injury was used [16]. In order to induce a wider range of mitochondrial disruption and myocardial injury, half the animals
were treated prior to ischemia with Cyclosporin A (CsA). In
this rabbit model, CsA has been shown to inhibit mitochondrial
permeability transition pore opening at reperfusion following
myocardial ischemia resulting in significantly less necrotic and
apoptotic myocyte death [17].
The combination of within group (small differences in ischemic zone size due to varying coronary anatomy) and between group (CsA protection) provides a desirable spectrum of
myocardial insults with which to correlate RR measurements.
A. Surgical Protocol
Animals are treated under experimental protocols approved
by the University of Pennsylvania’s Institutional Animal Care
and Use Committee (IACUC) and in compliance with National
Institutes of Health Publication No. 85-23, revised 1996.
Thirteen New Zealand white rabbits (3.2–4.0 kg) were studied
in two experimental groups:
1) untreated (UnT) (n = 7): 1-h continuous 20 mL infusion
of saline given intravenously prior to ischemia;
2) cyclosporine A (CsA) treatment (n = 6): 1-h continuous
20 mL infusion of a solution of saline and CsA (25 mg/kg)
given intravenously prior to ischemia.
Anesthesia was induced with intramuscular ketamine (70–
100 mg/kg), glycopyrrolate (0.01 mg/kg) and buprenorphine
(0.05 mg/kg). After oral endotracheal intubation, animals
were mechanically ventilated (Hallowell EMC Model AWS,
Pittsfield, MA, USA) with air enriched with 0.6 L/min of oxygen. Anesthesia was maintained with continuous ketamine infusion (20 mg/kg/hr IV). A high-fidelity pressure transducer (Millar Instruments Inc. Houston, TX, USA) was placed in the left
ventricle via carotid artery for continuous LV pressure measurement. Peripheral arterial blood pressure, heart rate, and surface
electrocardiogram (ECG) were also continuously monitored
(Hewlett Packard 78534C, Palo Alto, CA, USA) and recorded
(Sonometrics Inc., London, ON, Canada). Left atrial blood temperature was measured with an electrical thermometer (Thermalert TH-8 Physiotemp Instrument, Clifton, NJ, USA) and was
maintained between 39 ◦ C to 40 ◦ C (normal rabbit body temperature) with a high efficiency water blanket (Medi-Therm III,
Gaymar Industries Inc., Orchard Park, NY, USA).
Next, all animals received a 1-h, continuous 20 mL infusion
of a phosphate buffered saline (PBS) vehicle (UnT), 25 mg/kg
of CsA. A left thoracotomy was performed in the fourth intercostal space and the heart was exposed. A pledgetted suture
(3-0 Ti-cron, U.S. Surgical, Norwalk, CT, USA) was passed
around a large branch of the circumflex coronary artery at a distance 50% from the base of the heart toward the apex. Myocardial ischemia was achieved by tightening the coronary artery
snare and confirmed by ST elevations on ECG and by the distinct color change of the myocardium. After 30 min of ischemia,
the coronary artery snare was released and the myocardium was
reperfused for 180 min.

Fig. 1. Two-wavelength time-shared fluorometer in rabbit heart ratiometric
measurements.

To provide a specimen of normal myocardium, one rabbit underwent the same protocol as the UnT group with the exception
that no coronary was ligated and no ischemia induced.
B. Myocardial Fluorescence Spectroscopy
Fluorescence spectroscopy of rabbit myocardium in vivo was
conducted with a fluorometer (Fig. 1). This fluorometer is a
mobile optical–electrical apparatus that collects fluorescence
signals of any type of tissue through a 3-mm-tip light guide.
The incident light is a broadband mercury arc lamp that can
be filtered at four different wavelengths by an air turbine filter wheel rotating at 50 Hz. Consequently, up to four signals
could be multiplexed to a photodetector in order to make fourwavelength channel optical measurements of tissue metabolism
as shown in Fig. 1. In this experiment, two channels are used
for excitation and the other two for emission signals. The light
intensity that is incident on tissue at the fiber tip is 3 µW.
In cardiac fluorometry experiments, the excitation wavelengths of FP and NADH are obtained by filtering the mercury
arc lamp at 436 nm and 366 nm resonance lines by interference
filters 440DF20 and 365HT25 (Omega Optical, Brattleboro,
VT, USA). The fluorescence intensities are then detected by a
photomultiplier tube (PMT model R928, Hamamatsu, Japan),
converted to an electric voltage, digitized, and displayed. A
standard protocol for the fluorometer calibration is used at the
beginning of each single experiment. Fluorescent standards are
used from which we measure the fluorescent light at the wavelengths of interest for the upcoming experiment. We take these
standard measurements into account if any adjustment factor is
needed to apply to the experimental results. Specific instrument
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stained by double staining technique for identification of area
at risk. The thickness of each slice was measured with a digital micrometer and a standardized digital photograph was taken
(Casio EX-Z850, Tokyo, Japan). Infarct area (I/AR) was delineated by photographing and measuring the slices after 20
min of incubation in 2% triphenyltetrazolium chloride (TTC) at
37 ◦ C. All photographs were imported into an image analysis
program (Image Pro Plus, Media Cybernetics, Silver Spring,
MD, USA) and computerized planimetry was performed. The
AR is expressed as a percentage of the LV, and the infarct size
is expressed as a percentage of the AR (I/AR).

D. Transmission Electron Microscopy

Fig. 2. Double staining technique used to identify the area at risk (AR) and
the region of infarction in both the UnT group (A) and the CSA group (B). Both
hearts have been sliced perpendicular to the long axis. Blue-purple myocardium
has been stained by both Evans blue dye indicating it is outside the area at risk
and by triphenyl-tetrazolium (TTC) indicating it is viable. Within the area at
risk (no blue staining) viable myocardium has been stained dark red by TTC
while the pale infracted regions have not. Notice the smaller infarct region in
the CSA group.

specifications are kept the same for all the experiments (e.g.
PMT high voltage, channel gain factors, etc.).
The fluorometer probe was placed on the epicardial surface in
the center of the anticipated region of ischemia and continuous
recording of the fluorescence signals for FP and NADH signals
was performed during baseline (60 min infusion of saline or
CsA), ischemia (30 min), and reperfusion (180 min). The redox
ratio is calculated as FP/(FP + NADH) every 5 min from the
continuously recorded FP and NADH. All the redox ratio data
points are then normalized by the value at time point t = 0.
These normalized redox ratios (RRs) in each group (UnT = 7
and CsA = 6) are averaged and expressed as mean ± standard
deviation at 5-min time points for statistical analysis and 10minute intervals for spectroscopic graphs.
C. Analysis of Area at Risk and Infarct Size
At the end of the protocol, the coronary snare was reapplied,
vascular clamps were used to occlude the aorta, pulmonary
artery, and inferior vena cava, and the right atrium was incised.
Five milliliters of Evans blue dye (1%) (Sigma, St. Louis, MO,
USA) was injected via the left atrium to delineate the ischemic
myocardial risk area (AR). The heart was arrested with an
intraatrial bolus of 20 mEq of potassium chloride and was explanted. The left ventricle was sectioned perpendicular to its
long axis into six to seven slices. Fig. 2 illustrates these slices

To confirm the effect of CsA on mitochondrial integrity, punch
biopsies from directly under fluorometric probe were taken from
two animals in the UnT group, two animals in the CsA group,
and the one normal animal at the conclusion of the reperfusion protocol. Each of these biopsies was preserved in electron
microscopy fixative (2.5% glutaraldehyde, 2.0% paraformaldehyde, 0.1 M sodium cacodylate) for 24 h at 4 ◦ C. After several
washes in 0.1 M NaCaC, samples were postfixed with buffered
2% osmium tetroxide for 1 h at 4◦ C. Subsequent washes in
0.1 M NaCaC, H2 O, and 2% aqueous uranyl acetate were then
used to destain samples. Tissue samples were dehydrated in
serial washes of EtOH and propylene oxide, prior to a slow infiltration with EPON 812. Finally, samples were cured at 70 ◦ C
for 48 h.
Cured samples were submitted to the Biomedical Imaging
Core Facility at the University of Pennsylvania, where they were
cut, stained, and imaged on a Jeol-10-10 transmission electron
microscope (Jeol Ltd, Akishima, Japan). Random images were
captured from each sample for comparative analysis. To assess
the degree of mitochondrial disruption, five random images of
mitochondria at 30 000X were captured from two control, two
CsA-treated, and one normal rabbit. The number of disrupted
mitochondria was tallied, along with the total number of mitochondria. The percent disrupted mitochondrion (PDM) was
then determined, averaged for each group, and reported.

E. Statistical Analysis
Group results for the RR, I/AR and PDM are expressed
as the mean ± standard deviation. The RR was calculated at
5 min intervals during the entire experiment for all animals. To
assess between-group differences in the RR during preischemia,
ischemia, and postischemia, analysis of variance (ANOVA) was
used. Where ANOVA revealed significant differences, Student’s
T -test was used to compare the groups at individual time points.
Postmortem values for I/AR and PDM were compared using
Student’s T -test.
At each time point, the RR was correlated with both the
I/ARs using Pearson’s correlation test. A p-value < 0.05 was
considered statistically significant. The software package used
for the statistical analysis was SPSS version 11.0 for Windows
(SPSS Inc., Chicago IL, USA).

Authorized licensed use limited to: University of Pennsylvania. Downloaded on October 13, 2009 at 11:16 from IEEE Xplore. Restrictions apply.
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Fig. 3. Comparison of area at risk and infarct sizes between the UnT group and
the CsA group. Values are means ± standard deviation. The AR is expressed as
a percentage of the LV (AR/LV), and the infarct size is expressed as a percentage
of the AR (I/AR). Statistically significant difference from UnT group (p < 0.01)
is indicated by ∗ .

III. RESULTS
A. Infarct Size Measurements
The two-group model produced a varying degree of infarcted
myocardium. The AR was similar in both groups: 27.0 ± 8.1%
in the UnT group and 26.5 ± 9.1% in the CsA group. The I/AR
was significantly smaller in the CsA group than in the UnT
(39.1 ± 4.4% vs. 53.4 ± 4.7%, p < 0.0001) (Fig. 3).
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Fig. 4. Comparison of mitochondrial changes in the electron microscopy
imaging between the UnT group, the CsA group, and normal group. Normally,
the nuclear cap, or region surrounding the nucleus, is tightly packed with mitochondria (C, F). Although not as densely packed with mitochondria as the
normal group, tightly packed mitochondria were still present in the nuclear caps
of the CsA group (B). Most mitochondria of the CsA-treated animals had welldefined outer membranes. Although a small percentage of the mitochondria had
dilated cristae, the majority of the CsA cristae exhibited normal characteristics
(E). The nuclear caps of the UnT group were either absent of mitochondria
or possessed mitochondria with disrupted outer membranes and tightly packed
cristae, vacuolated mitochondria with poorly defined outer membranes, or mitochondria absent of an outer membrane and unraveling cristae (A, D). For all
three groups, the mitochondria between the muscle fibers possessed characteristics similar to what was found in the nuclear cap of the respective group.
(A) UnT-12000X. (B) CsA-12000X. (C) Normal-12000X. (D) UnT-30000X.
(E) CsA-30000X. (F) Normal-30000X.

B. Mitochondrial Disruption
The protective effect of CsA on reperfused myocardium was
also quite evident in the myocardial samples studied with EM
(Fig. 4). The majority of the myocytes in all three groups (one
normal, two UnT, and two CsA-treated rabbits) had nuclei with
a ruffled membrane and normally distributed heterochromatin.
The nuclear membranes of the normal and the CsA groups
were also smooth, while several abnormally shaped nuclei were
found in the UnT group. Normally, the nuclear cap, or region
surrounding the nucleus, is tightly packed with mitochondria.
Although not as densely packed with mitochondria as the normal group, tightly packed mitochondria were still present in the
nuclear caps of the CsA group. Most mitochondria of the CsAtreated animals had well-defined outer membranes. Although
a small percentage of the mitochondria had dilated cristae, the
majority of the CsA cristae exhibited normal characteristics. The
nuclear caps of the UnT group were either absent of mitochondria or possessed mitochondria with disrupted outer membranes
and tightly packed cristae, vacuolated mitochondria with poorly
defined outer membranes, or mitochondria absent of an outer
membrane and unraveling cristae. For all three groups, the mitochondria between the muscle fibers possessed characteristics
similar to what was found in the nuclear cap of the respective
group. The percent disrupted mitochondria for the UnT group
was 53.31% ± 16.47%, for the CsA group, 19.71% ± 9.64%,
and for the normal group 1.65% (Fig. 5).

Fig. 5. Comparison of the percent disrupted mitochondria (PDM) between
the UnT group, the CsA group, and normal group. Values are means ± standard
deviation. PDM = percent disrupted mitochondria.

C. Redox Fluorometry
Fig. 6 presents the RR at 10 min intervals during the entire protocol. The RR remained constant in both groups during
the pre-ischemic CsA/saline infusion period demonstrating that
CsA had no effect on the mitochondrial metabolic state of normally perfused myocardium.
In both groups, the RR drops immediately with the onset of
ischemia and continues to drop steadily during the entire 30 min.
This is consistent with marked reduction in the oxidative state
of the fluorophores due to decreased oxygen availability. That
is, NADH and FP remain in their reduced form due to backup of
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Fig. 6. Comparison of mean normalized redox ratio between the UnT group
and CsA group throughout the experiment. Statistically significant difference
between the UnT and CsA groups (p < 0.05) is indicated by filled circle and
triangle. Error bars represent twice the standard deviation.

Fig. 7. Plot of infarct size versus normalized redox ratio at 15 min of reperfusion in the UnT group and the CsA group.

TABLE I
CORRELATIONS BETWEEN RR AND I/AR AFTER REPERFUSION

Fig. 8. Plot of infarct size versus normalized redox ratio at 180 min of reperfusion in the UnT group and the CsA group.

the electron transport chain. The rate at which the RR decreased
was slightly less in the CsA group (Fig. 6), but this trend did not
reach statistical significance.
With the reinstitution of blood flow, the RR increased immediately in both groups. In the UnT group, the RR increased
persistently by 53.1 ± 6.8% over normal during the 180 min
of reperfusion. This drastic increase in the RR represents a
“hyper-oxidation” of fluorophores and is indicative of dysfunctional mitochondria that are unable to reduce NAD+ and FP
thus preventing their entry into the electron transport chain and
ultimately the production of adenosine triphosphate. In the CsA
group, the RR ratio only increases by 17.0 ± 11.0% of normal
demonstrating less mitochondrial dysfunction.
During the first 15 min after reperfusion the RR increases
almost linearly in both groups but with a much greater slope in
the UnT group. After 15 min of reperfusion, the RR of the UnT
group is significantly greater than that of the CsA group. After
30 min, the RR changes very little in the CsA group.
Table I demonstrates the correlation between the RR and
I/AR at 15-min time intervals after reperfusion. It can be seen
that as early as 15 min after reperfusion, the RR ratio correlates

strongly with infarct size. Figs. 7 and 8 are scatter plots of the RR
versus the I/AR that demonstrate the predictive strength of the
correlation at 15 and 180 min after reperfusion, respectively.
IV. DISCUSSION
Mitochondrial permeability transition (MPT) pore opening
is recognized as a pivotal event in necrotic and apoptotic cell
death [18], [19]. Following myocardial ischemia-reperfusion
injury, opening of this nonspecific pore results in inner membrane potential collapse, uncoupling of the respiratory chain,
and efflux of small molecules such as cytochrome c and other
proapoptotic factors [20]. CsA is a powerful inhibitor of the
MPT pore, and several reports indicate that it protects the isolated heart from ischemia-reperfusion injury [17]. In this study,
the protective role of CsA was confirmed in vivo and exploited to
provide an experimental model with a spectrum of reperfusioninduced mitochondrial dysfunction and resulting myocardial injury. This model was used to test the hypothesis that changes
in mitochondrial NADH and FP fluorescence can be measured
and correlated with myocardial injury.
Our data indicates that myocardial reperfusion injury is associated with mitochondrial disruption, which is significantly
blunted by CsA, and that this injury correlates very strongly
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with the RR as measured by fluorometry. This is particularly
compelling considering that the fluorometric measurements of
NADH and FP were made over a relatively small epicardial region of the area at risk. We found it equally interesting that even
very early after reperfusion (15 min), the RR began to correlate
with infarct size at 3 h postreperfusion.
These data provide convincing evidence that fluorometry can
be used to clinically assess myocardial injury noninvasively
without tissue biopsy. Such a tool will provide a better early
evaluation of the effectiveness of reperfusion therapy and potentially identify patients that are at increased risk for postinfarction ventricular remodeling. Early identification of such patients
would allow the institution of more aggressive infarct restraint
procedures to prevent heart failure than would be justifiable
without proper patient identification.
Apoptotic-induced mitochondrial dysfunction is associated
with established chronic heart failure [21] as well as myocardial rejection after heart transplantation [22]. Both these disease
states are currently treated with complex pharmacological strategies that can be hard to optimize. Considering the findings of
this study, it is possible that fluorometry may be used to assess
and monitor the progression of these diseases without tissue
biopsy and allow physicians to make more informed decisions
regarding drug selection and dosing.
To prove the clinical applicability of this technology, we are
currently in the process of designing human experiments in
which the redox ratio will be correlated with mitochondrial disruption as measured by electron microscopy in cardiovascular
specimens. The first human experiments will be conducted on
patients with end-stage heart failure requiring placement of a
ventricular assist device (VAD). During VAD placement, a portion of the failing LV is routinely removed. Prior to excision
of the myocardium, the redox ratio will be measured. The myocardium will then be removed and assessed for mitochondrial
disruption using the electron microscopic techniques described
in this manuscript and the two measurements correlated.
While development hurdles persist, one can envision a
catheter-based fluorometer that will be introduced via standard
percutaneous venous or arterial techniques to assess the myocardial injury associated with reperfusion, ventricular remodeling,
and allograft rejection. We believe that in human application,
transvascular approaches will allow the fluorometric catheter to
be placed directly on the tissue of interest and that signal quality
will be very similar to those reported in this manuscript. Such
a technology would improve the care of these very complex
patients while at the same time minimizing their discomfort and
treatment risk.
ACKNOWLEDGMENT
M. Ranji and M. Matsubara have contributed equally to the
preparation of this manuscript.
REFERENCES
[1] M. Gheorghiade and R. O. Bonow, “Chronic heart failure in the United
States: A manifestation of coronary artery disease,” Circulation, vol. 97,
no. 3, pp. 282–289, Jan. 1998.

1561

[2] J. Narula, M. S. Dawson, B. K. Singh, A. Amanullah, E. R. Acio,
F. A. Chaudhry, R. B. Arani, and A. E. Iskandrian, “Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium
in ischemic cardiomyopathy,” J. Amer. Coll. Cardiol., vol. 36, no. 6,
pp. 1913–1918, Nov. 2000.
[3] A. Yamaguchi, T. Ito, H. Adachi, S. Murata, H. Kamio, M. Okada, and
J. Tsuboi, “Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy,” Ann. Thorac. Surg., vol. 65, no. 2,
pp. 434–438, Feb. 1998.
[4] A. S. Blom, R. Mukherjee, J. J. Pilla, A. S. Lowry, W. M. Yarbrough,
J. T. Mingoia, J. W. Hendrick, R. E. Stroud, J. E. McLean, J. Affuso,
R. C. Gorman, J. H. Gorman, III, M. A. Acker, and F. G. Spinale, “Cardiac
support device modifies left ventricular geometry and myocardial structure
after myocardial infarction,” Circulation, vol. 112, no. 9, pp. 1274–1283,
Aug. 2005.
[5] J. J. Pilla, A. S. Blom, J. H. Gorman, III, D. J. Brockman, J. Affuso,
L. M. Parish, H. Sakamoto, B. M. Jackson, M. A. Acker, and R. C.
Gorman, “Early postinfarction ventricular restraint improves borderzone
wall thickening dynamics during remodeling,” Ann. Thorac. Surg., vol. 80,
no. 6, pp. 2257–2262, Dec. 2005.
[6] Y. Enomoto, J. H. Gorman, III, S. L. Moainie, B. M. Jackson, L. M. Parish,
T. Plappert, A. Zeeshan, and M. G. St. John-Sutton, R. C. Gorman, “Early
ventricular restraint after myocardial infarction: Extent of the wrap determines the outcome of remodeling,” Ann. Thorac. Surg., vol. 79, no. 3,
pp. 881–887, Mar. 2005.
[7] R. G. McKay, M. A. Pfeffer, R. C. Pasternak, J. E. Markis, P. C. Come,
S. Nakao, J. D. Alderman, J. J. Ferguson, R. D. Safian, and W. Grossman,
“Left ventricular remodeling after myocardial infarction: A corollary to
infarct expansion,” Circulation, vol. 74, no. 4, pp. 693–702, Oct. 1986.
[8] J. A. Erlebacher, J. L. Weiss, L. W. Eaton, C. Kallman, M. L. Weisfeldt,
and B. H. Bulkly, “Late effects of acute infarct dilatation on heart size:
A two dimensional echocardiographic study,” Amer. J. Cardiol., vol. 49,
no. 5, pp. 1120–1126, Apr. 1982.
[9] R. A. Gottlieb, K. O. Burleson, R. A. Kloner, B. M. Babior, and R. L.
Engler, “Reperfusion injury induces apoptosis in rabbit cardiomyocytes,”
J. Clin. Invest, vol. 94, no. 4, pp. 1621–1628, Oct. 1994.
[10] H. J. Bromme and J. Holtz, “Apoptosis in the heart: When and why?,”
Mol. Cell. Biochem., vol. 261–275, pp. 163–164, Oct.–Nov. 1996.
[11] H. L. Wyatt, S. Meerbaum, M. K. Heng, J. Rit, P. Gueret, and E. Corday,
“Experimental evaluation of the extent of myocardial dyssynergy and
infarct size by two-dimensional echocardiography,” Circulation, vol. 63,
no. 3, pp. 607–614, Mar. 1981.
[12] N. G. Pandian, S. Koyanagi, D. J. Skorton, S. M. Collins, C. L. Easthm,
R. A. Kieso, M. L. Marcus, and R. E. Kerber, “Relations between 2dimensional echocardiographic wall thickening abnormalities, myocardial infarct size and coronary risk area in normal and hypertrophied myocardium in dogs,” Amer. J. Cardiol., vol. 52, no. 10, pp. 1318–1325,
Dec. 1983.
[13] B. Chance and H. Baltscheffsky, “Respiratory enzymes in oxidative phosphorylation. VII. Binding of intramitochondrial reduced pyridine nucleotide,” J. Biol. Chem., vol. 233, no. 3, pp. 736–739, Sep. 1958.
[14] B. Chance and B. Schoener, “High and low energy states of cytochromes.
II. In submitochondrial particles,” J. Biol. Chem., vol. 241, no. 20,
pp. 4577–4587, Oct. 1966.
[15] M. Ranji, S. Kanemoto, M. Matsubara, M. A. Grosso, J. H. Gorman III,
R. C. Gorman, D. L. Jaggard, and B. Chance, “Fluorescence spectroscopy
and imaging of myocardial apoptosis,” J. Biomed. Opt., vol. 11, no. 6,
pp. 064036-1–064036-4, Nov.–Dec. 2006.
[16] B. G. Leshnower, H. Sakamoto, A. Zeeshan, L. M. Parish, R. Hinmon,
T. Plappert, J. H. Gorman III,, and R. C. Gorman, “Role of acetaminophen
in acute myocardial infarction,” Amer. J. Physiol. Heart Circ. Physiol.,
vol. 81, no. 4, pp. 2424–2431, Jun. 2006.
[17] L. Argaud, O. Gateau-Roesch, D. Munteam, L. Chalabreysse, J. Loufouat,
D. Robert, and M. Ovize, “Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury,” J. Mol. Cell. Cardiol,
vol. 38, no. 2, pp. 367–374, Feb. 2005.
[18] G. Kroemer, B. Dallaporta, and M. Resche-Rignon, “The mitochondrial
death/life regulator in apoptosis and necrosis,” Annu. Rev. Physiol.,
vol. 60, pp. 619–642, 1998.
[19] M. R. Duchen, O. McGuiness, L. A. Brown, and M. Crompton, “On the
involvement of a cyclosporin a sensitive mitochondrial pore in myocardial
reperfusion injury,” Cardiovasc. Res., vol. 27, no. 10, pp. 1790–1794, Oct.
1993.
[20] M. Zoratti and I. Szabo, “The mitochondrial permeability transition,”
Bichim. Biophys. Acta, vol. 1241, no. 2, pp. 139–176, Jul. 1995.

Authorized licensed use limited to: University of Pennsylvania. Downloaded on October 13, 2009 at 11:16 from IEEE Xplore. Restrictions apply.

1562

IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. 56, NO. 5, MAY 2009

[21] J. Narula, N. Haider, R. Virmani, T. G. DiSalvo, F. D. Kolodgie,
R. J. Hajjar, U. Schmidt, M. J. Semigran, G. W. Dec, and B. A. Khaw,
“Apoptosis in myocytes in end-stage heart failure,” N. Engl. J. Med.,
vol. 335, no. 16, pp. 1182–1189, Oct. 1996.
[22] J. Narula, E. R. Acio, N. Narula, L. E. Samuels, B. Fyfe, D. Wood, J. M.
Fitzpatrick, P. N. Raghunath, J. E. Tomaszewski, C. Kelly, N. Steinmetz,
A. Green, J. F. Tait, J. Leppo, F. G. Blankenberg, D. Jain, and H. W. Strauss,
“Annexin-V imaging for noninvasive detection of cardiac allograft rejection,” Nat. Med., vol. 7, no. 12, pp. 1347–1352, Dec. 2001.
Mahsa Ranji (S’06) received the B.Sc. degree from
Sharif University, Tehran, Iran, in 1988, the M.Sc.
degree from Khajeh Nasir Toosi University, Tehran,
Iran, in 2000, and the Ph.D. degree in electrical and
systems engineering from the University of Pennsylvania, Philadelphia, in December 2007, under the
supervision of Prof. Chance and Prof. Jaggard in collaboration with Gorman laboratory.
She has currently started postdoctoral research in
fluorescence studies of stem cells at the Burnham Institute for Medical Research/University of California
San Diego Bioengineering, La Jolla, CA. Her current research interests include
fluorescence spectroscopy and imaging for biomedical applications. Particularly, she has collaborated with the Surgery Department, University of Pennsylvania for developing optical techniques for diagnosis of myocardial infarction
(heart attack) and its possible clinical transferability.
Dr. Ranji is a member of WIE, the Optical Society of America, and the
International Society for Optical Engineering.
Muneaki Matsubara received the M.D. degree, in
1998, from Tsukuba University School of Medicine,
Tsukuba, Japan.
During 2005–2007, he was with the Gorman Cardiovascular Research Group, University of Pennsylvania, where he was engaged in research on myocardial ischemia/reperfusion injury. He is currently
a Chief Resident in cardiothoracic surgery at the
Tsukuba University Hospital, Tsukuba. His current
research interests include the pathophysiology and
treatment of heart failure, ventricular assist device
design, percutaneous valve repair/replacement and cardiac imaging.

Bradley G. Leshnower received the B.S. degree in
cello performance from the University of Texas at
Austin, Austin, and the M.D. degree from the University of Texas Southwestern Medical School, Austin.
He completed the general surgery training at
the University of Pennsylvania, where he was also
a Research Fellow with the Gorman Cardiovascular Research Group. He is currently a Resident in cardiothoracic surgery at Emory University,
Atlanta, GA. His current research interests include
ischemia/reperfusion injury.
Robin H. Hinmon received the B.A. degree in biology education, in 1997, from the University of
Delaware Honors Program, Newark. She is currently
working toward the M.S. degree at the University of
the Sciences in Philadelphia, Philadelphia, PA, where
she was engaged in characterizing the taxonomic relationship among Agrobacterium tumefaciens, A. rhizogenes, and Rhizobium leguminosarum.
In 2002, she accepted an immunohistochemistry
research position at the University of Pennsylvania
in the Laboratory of Robert C. Gorman, M.D., and
Joseph H. Gorman, III, M.D., where large and small animal models were used to
characterize heart failure and valve disease. She enriched the pathophysiology
studies by introducing immunofluorescence, confocal microscopy, and transmission electron microscopy. She currently manages all laboratory research for
the Gorman Cardiovascular Research Group. Her studies are focused on characterizing apoptosis in the heart from a molecular, protein, and pathophysiological
viewpoint.

Dwight L. Jaggard (S’68–M’77–SM’86–F’91) was
born in Oceanside, NY. He received the B.S.E.E. and
M.S.E.E. degrees from the University of Wisconsin,
Madison, in 1971 and 1972, respectively, and the
Ph.D. degree in electrical engineering and applied
physics from California Institute of Technology (Caltech), Pasadena, in 1976.
From 1976 to 1978, he was a Postdoctoral Research Fellow at Caltech and a Consultant to the Jet
Propulsion Laboratory. In 1978, he joined the faculty
at the University of Utah, Salt Lake City, as an Assistant Professor of electrical engineering. Since 1980, he has been engaged
in research on complex media, scattering and inverse scattering, and highresolution imaging at the Moore School of Electrical Engineering, University
of Pennsylvania, Philadelphia. He was an Associate Dean for graduate education and research in the School of Engineering and Applied Science from 1992
through 1999, and is currently a Professor of systems and electrical engineering
and Director of the Executive Master’s of Technology Management Program
at the University of Pennsylvania, where he co-founded the Complex Media
Laboratory in the Department of Electrical and Systems Engineering. He is the
Co-Editor of and contributor to the book Recent Advances in Electromagnetic
Theory (Springer-Verlag, 1990), and is a contributor to the books Symmetry in
Electromagnetics (Taylor and Francis, 1995), Fractals in Engineering (Springer,
1997), Fractals: Theory and Applications in Engineering (Springer, 1999), and
Frontiers of Electromagnetics (IEEE Press, 2000). He holds a patent. His current
research interests include characteristics and applications of fractal electrodynamics to scattering and radiation, problems in inverse scattering; applications
of biooptics, and the effects of knot symmetry and topology on waves.
Prof. Jaggard is a Fellow of the Optical Society of America, and a member
of the Electromagnetics Academy. He has served as an Editor of the Journal of
Electromagnetic Wave Applications and Editor of several special sections of the
Journal of the Optical Society and the PROCEEDINGS OF THE IEEE regarding
fractals and their applications. He was a Member of the Editorial Board of the
PROCEEDINGS OF THE IEEE. He was the recipient of numeous awards including
the S. Reid Warren Award for Distinguished Teaching, the Christian F. and
Mary R. Lindback Award for Distinguished Teaching, and the EMTM Award
for Excellence in Teaching.

Britton
Chance
(M’46–SM’46–F’54–LF’81)
received the Ph.D. degree in physical chemistry, in
1940, from University of Pennsylvania, Philadelphia,
and the Ph.D. degree in biology and physiology in
1942 and the honorary D.Sc. degree ten years later,
both from Cambridge University, Cambridge, U.K.
He became a member of the University of
Pennsylvania faculty in 1941 as an Assistant
Professor of biophysics and physical biochemistry
in the School of Medicine. He served as a Professor
of biophysics and physical biochemistry from 1949
until 1983 in the School of Medicine, University of Pennsylvania. He was also
the Director of the E. R. Johnson Foundation in the School of Medicine for this
entire period. Since 1983, he has continued at the University of Pennsylvania
and is currently the Eldridge Reeves Johnson University Professor Emeritus
of biophysics, physical chemistry, and radiologic physics. He is also a Senior
Visiting Scientist at the Singapore Bioimaging Consortium, Helios, Singapore.
He has made contributions not only in the identification and functioning
of enzyme-substrate compounds, but also in areas of magnetic resonance
spectroscopy in humans, the mathematics of the inverse problem, light transport
in highly scattering media, breast cancer diagnostics, and muscle dynamics.
He has been a pioneer in the field of biomedical optics, including the efforts to
develop spectroscopy as a noninvasive analytical tool for clinical diagnosis.
He is the author or coauthor of more than 2000 original articles, chapters and
reviews. He has mentored over 300 graduate students and postdocs. His current
research interests include mitochondrial metabolism and tissue oxygenation.
He has developed spectroscopic and imaging methods for breast cancer
detection, cognitive function, myocardium redox states, and muscle function.
Prof. Chance is a Fellow of the Optical Society of America. He was elected
to the National Academy of Science in 1954. He was the recipient of numerous
awards including the Olympic Gold Medal for the U.S. Yacht team in 1952,
the Pennsylvania Award for Excellence (Life Sciences), in 1968, the National
Medal of Science in 1974, and the Lifetime Achievement Award from the
International Society for Optical Engineering in 2005.

Authorized licensed use limited to: University of Pennsylvania. Downloaded on October 13, 2009 at 11:16 from IEEE Xplore. Restrictions apply.

RANJI et al.: QUANTIFYING ACUTE MYOCARDIAL INJURY USING RATIOMETRIC FLUOROMETRY

Robert C. Gorman received the B.S. degree (summa
cum laude) in chemical engineering from the New
Jersey Institute of Technology, Newark, NJ, and the
M.D. degree from the University of Medicine and
Dentistry of New Jersey, Stratford, NJ.
He completed residencies in general surgery and
cardiothoracic surgery at the Hospital of the University of Pennsylvania and Children’s Hospital of
Philadelphia. While a resident, he completed a twoyear National Institutes of Health funded postdoctoral fellowship in the laboratory of Henry Edmunds
during which he did groundbreaking research to elucidate the mechanism of
ischemic/functional mitral regurgitation. He is currently an Associate Professor
of surgery and Director of Cardiac Surgical Research, Gorman Cardiovascular
Research Group, University of Pennsylvania, Philadelphia. He is board certified
in both general and cardiothoracic surgery. His clinical focus is on adult cardiac
surgery with a particular emphasis on valvular heart disease, aortic disease,
ventricular assist devices, heart and lung transplantation, and heart failure. He
also directs a heart failure and device design laboratory. He is the author or
coauthor of more than 130 original articles, chapters, and reviews. He has mentored over 20 postdoctoral fellows, medical students, and undergraduates. His
current research interests include the pathophysiology and treatment of heart
failure, ventricular assist device design, percutaneous valve repair/replacement,
cardiac imaging with MRI, CT and real-time 3-D echocardiography, mitral
valve physiology, ventricular pacing for heart failure, valve calcification, and
biocompatibility of synthetic surfaces. He has served on numerous study sections and advisory committees for both the National Institutes of Health and the
American Heart Association.
Dr. Gorman has recently been the recipient of a prestigious Established Investigator Award from the American Heart Association.

1563

Joseph H. Gorman, III, received the B.S. degree (summa cum laude) in chemical engineering from the New Jersey Institute of Technology,
Newark, NJ, and the M.D. degree (with honors) from
the University of Medicine and Dentistry of New
Jersey, Stratford, NJ.
He completed residencies in general surgery and
cardiothoracic surgery at the Hospital of the University of Pennsylvania., Philadelphia. While a resident,
he completed a two-year National Institutes of Health
funded postdoctoral fellowship in the laboratory of
Henry Edmunds during which he did groundbreaking research in the field of
cardiac remodeling, mitral valve disease, and cardiac imaging. He currently codirects the Gorman Cardiovascular Research Group, University of Pennsylvania.
He is board certified in both general and cardiothoracic surgery. In addition to
his research activities, he also performs an extensive amount of esophageal
surgery for malignant and benign disease. He also directs a heart failure and
device design laboratory. He is the author or coauthor of more than 100 original
articles, chapters, and reviews. He has mentored over 20 postdoctoral fellows,
medical students, graduate students, and undergraduates. His current research
interests include the pathophysiology and treatment of heart failure, ventricular
assist device design, percutaneous valve repair/replacement, cardiac imaging
with MRI, CT and real-time 3-D echocardiography and near-IR spectroscopy,
mitral valve physiology, ventricular pacing for heart failure, valve calcification,
and biocompatibility of synthetic surfaces. He has served on numerous study
sections and advisory committees for both the National Institutes of Health and
the American Heart Association.

Authorized licensed use limited to: University of Pennsylvania. Downloaded on October 13, 2009 at 11:16 from IEEE Xplore. Restrictions apply.

